WJPPS Citation Report

Submit Article

Search

News & Updation

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: New Impact Factor 2026
  • WJPPS Impact Factor has been Increased to 8.485 for Year 2026.

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2026 Issue has been successfully launched on 1 NOVEMBER 2026.

Abstract

GLOBAL REGULATORY PATHWAYS AND DESIGN CONTROL STANDARDS FOR HIGH-RISK CARDIOVASCULAR MEDICAL DEVICES: A COMPARATIVE REVIEW OF THE USA, EUROPEAN UNION AND INDIA

Karan Sharma, Keshav*

ABSTRACT

High-risk cardiovascular medical devices, such as implantable pacemakers, implantable cardioverter-defibrillators (ICDs), coronary stents, prosthetic and transcatheter heart valves and ventricular assist devices, sustain or restore essential physiological functions, and their failure may lead to serious injury or death. These devices are therefore subject to the most stringent regulatory control in every major regulatory authority. Although regulatory systems share a common risk-based philosophy, they differ in classification terminology, pre-market pathways, conformity assessment, the explicitness of design-control requirements and the use of international standards. This review compares the regulatory frameworks of the United States of America (USA), the European Union (EU) and India with respect to risk classification, pre-market pathways, quality management systems (QMS), design controls, risk management, device-specific international standards (ISO, IEC and ASTM) and post-market obligations. The comparison shows that all three systems converge on a common technical foundation: risk-based classification, a mandatory QMS, integrated risk management, verification and validation, documentation and lifecycle surveillance. The principal differences lie in regulatory architecture and terminology. Gaps requiring further harmonization include the management of design changes, long-term clinical evidence, adaptive approaches for innovative devices, real-world standards (ISO, IEC and ASTM) and post-market obligations. The comparison shows that all three systems converge on a common technical foundation: risk-based classification, a mandatory QMS, integrated risk management, verification and validation, documentation and lifecycle surveillance. The principal differences lie in regulatory architecture and terminology. Gaps requiring further harmonization include the management of design changes, long-term clinical evidence, adaptive approaches for innovative devices, real-world 

Keywords: high-risk cardiovascular devices; regulatory pathways; design controls; ISO 13485; ISO 14971; FDA PMA; EU MDR; Medical Devices Rules 2017; regulatory convergence.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More